Good reasons to vaccinate: mandatory or payment for risk?

por Savulescu, Julian
Publicado 2021

Sustainability principle for the ethics of healthcare resource allocation

por Munthe, Christian, Fumagalli, Davide, Malmqvist, Erik
Publicado 2021

Human rights and COVID-19 triage: a comment on the Bath protocol

por Bhatt, Vivek, Michalowski, Sabine, Wyllie, Aaron, Kuylen, Margot, Martin, Wayne
Publicado 2021

COVID-19 vaccination and the right to take risks

por Huang, Pei-hua
Publicado 2022

What can data trusts for health research learn from participatory governance in biobanks?

por Milne, Richard, Sorbie, Annie, Dixon-Woods, Mary
Publicado 2022

Machine learning in medicine: should the pursuit of enhanced interpretability be abandoned?

por Yoon, Chang Ho, Torrance, Robert, Scheinerman, Naomi
Publicado 2022

Lord Sumption and the values of life, liberty and security: before and since the COVID-19 outbreak

por Coggon, John
Publicado 2022

Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?

por Gyngell, Christopher, Savulescu, Julian
Publicado 2022

Vaccine mandates for healthcare workers beyond COVID-19

por Giubilini, Alberto, Savulescu, Julian, Pugh, Jonathan, Wilkinson, Dominic
Publicado 2023

Digital bioethics: introducing new methods for the study of bioethical issues

por Schneider, Manuel, Vayena, Effy, Blasimme, Alessandro
Publicado 2023

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma

por Murphy, N C, Scarlett, C J, Kench, J G, Sum, E Y M, Segara, D, Colvin, E K, Susanto, J, Cosman, P H, Lee, C-S, Musgrove, E A, Sutherland, R L, Lindeman, G J, Henshall, S M, Visvader, J E, Biankin, A V
Publicado 2008

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

por Sekine, I, Nokihara, H, Takeda, K, Nishiwaki, Y, Nakagawa, K, Isobe, H, Mori, K, Matsui, K, Saijo, N, Tamura, T
Publicado 2008

Childhood leukaemia and population movements in France, 1990–2003

por Bellec, S, Baccaïni, B, Goubin, A, Rudant, J, Ripert, M, Hémon, D, Clavel, J
Publicado 2008

Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma

por Gad, S, Lefèvre, S H, Khoo, S K, Giraud, S, Vieillefond, A, Vasiliu, V, Ferlicot, S, Molinié, V, Denoux, Y, Thiounn, N, Chrétien, Y, Méjean, A, Zerbib, M, Benoît, G, Hervé, J M, Allègre, G, Bressac-de Paillerets, B, Teh, B T, Richard, S
Publicado 2007

The decatenation checkpoint

por Damelin, M, Bestor, T H
Publicado 2007

Temporal trends in non-small cell lung cancer survival in Sweden

por Brooks, D R, Klint, Å, Dickman, P W, Ståhle, E, Lambe, M
Publicado 2007

Gene expression profiling for the diagnosis of acute leukaemia

por Haferlach, T, Kohlmann, A, Bacher, U, Schnittger, S, Haferlach, C, Kern, W
Publicado 2007

Vascular disrupting agents in clinical development

por Hinnen, P, Eskens, F A L M
Publicado 2007

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency

por Bulk, S, Berkhof, J, Rozendaal, L, Daalmeijer, N C Fransen, Gök, M, de Schipper, F A, van Kemenade, F J, Snijders, P J F, Meijer, C J L M
Publicado 2007

The future burden of cancer in England: incidence and numbers of new patients in 2020

por Møller, H, Fairley, L, Coupland, V, Okello, C, Green, M, Forman, D, Møller, B, Bray, F
Publicado 2007